Gerresheimer

Gerresheimer, founded in 1864, operates as a global leader in providing innovative systems and solutions for the pharma, biotech, and cosmetics industries. Their expansive portfolio includes pharmaceutical packaging, drug delivery systems, medical devices, and digital solutions, ensuring the safe delivery and reliable administration of drugs to patients.

Headquartered in Germany, Gerresheimer boasts a robust global presence with around 13,400 employees and more than 40 production sites across 16 countries in Europe, America, and Asia. This extensive network allows the company to produce locally for regional markets, optimizing distribution and service delivery.

The company recently received a $200.00M Post Ipo Debt investment on 01 August 2025, indicating strong investor confidence and providing a substantial capital infusion to potentially enhance its technological capabilities and market reach. With the tagline "Innovating for a better life," Gerresheimer continues to solidify its position as a trusted partner in its sector.